======= KCTD10 ======= == Gene Information == * **Official Symbol**: KCTD10 * **Official Name**: potassium channel tetramerization domain containing 10 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=83892|83892]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9H3F6|Q9H3F6]] * **Interactions**: [[https://thebiogrid.org/search.php?search=KCTD10&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20KCTD10|Open PubMed]] * **OMIM**: [[https://omim.org/entry/613421|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Substrate-specific adapter of a BCR (BTB-CUL3-RBX1) E3 ubiquitin-protein ligase complex. The BCR(BACURD3) E3 ubiquitin ligase complex mediates the ubiquitination of target proteins, leading to their degradation by the proteasome (By similarity). {ECO:0000250|UniProtKB:Q8WZ19}. |K tetra| |GTP-Rho binding| |negative regulation of Rho protein signal transduction| |Notch binding| |Cul3-RING ubiquitin ligase complex| |negative regulation of Ras protein signal transduction| |negative regulation of small GTPase mediated signal transduction| |regulation of Rho protein signal transduction| |regulation of Ras protein signal transduction| |ubiquitin-protein transferase activity| |proteasome-mediated ubiquitin-dependent protein catabolic process| |protein homooligomerization| |regulation of small GTPase mediated signal transduction| |proteasomal protein catabolic process| |negative regulation of intracellular signal transduction| |protein complex oligomerization| |ubiquitin-dependent protein catabolic process| |modification-dependent protein catabolic process| |modification-dependent macromolecule catabolic process| |proteolysis involved in cellular protein catabolic process| |cellular protein catabolic process| |protein catabolic process| |protein ubiquitination| |protein modification by small protein conjugation| |cellular macromolecule catabolic process| |protein modification by small protein conjugation or removal| |macromolecule catabolic process| |organonitrogen compound catabolic process| |negative regulation of signal transduction| |proteolysis| |negative regulation of cell communication| |negative regulation of signaling| |protein-containing complex assembly| |negative regulation of response to stimulus| |organic substance catabolic process| |cellular catabolic process| |regulation of intracellular signal transduction| |protein-containing complex subunit organization| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp524|Staurosporine 0.02μM R08 exp524]]|-2.56| |[[:results:exp355|Dinaciclib 0.007μM R07 exp355]]|-2.09| |[[:results:exp422|Wiskostatin 3μM R07 exp422]]|-2| |[[:results:exp474|CR131-b 0.005μM R08 exp474]]|-1.83| |[[:results:exp295|Pyronaridine 1μM R06 exp295]]|-1.78| |[[:results:exp189|Temozolomide 200μM R04 exp189]]|1.71| |[[:results:exp535|Trimetrexate 0.03μM R08 exp535]]|1.71| |[[:results:exp274|Citral 50μM R06 exp274]]|1.77| |[[:results:exp179|Combretastatin A4 0.002 to 0.003μM day4 R04 exp179]]|1.83| |[[:results:exp210|LB-100 2μM R05 exp210]]|3.33| |[[:results:exp72|LB-100 4.1μM R02 exp72]]|7.1| ^Gene^Correlation^ |[[:human genes:p:pebp1|PEBP1]]|0.434| Global Fraction of Cell Lines Where Essential: 57/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|2/28| |blood|1/28| |bone|5/26| |breast|6/33| |central nervous system|5/56| |cervix|1/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|1/16| |kidney|3/21| |liver|2/20| |lung|6/75| |lymphocyte|0/16| |ovary|2/26| |pancreas|1/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|1/24| |soft tissue|0/9| |thyroid|1/2| |upper aerodigestive|0/22| |urinary tract|5/29| |uterus|1/5| == Essentiality in NALM6 == * **Essentiality Rank**: 3628 * **Expression level (log2 read counts)**: 5.86 {{:chemogenomics:nalm6 dist.png?nolink |}}